Related Experiment Video
Updated: May 30, 2026

Standardization of Transfer across Labs between Flow Cytometers for Detection of Lymphocytes in Japanese Encephalitis Vaccinated Children
Published on: February 10, 2023
Evolution of laboratory values in patients with Kawasaki disease
Adriana H Tremoulet1, Sonia Jain, Divya Chandrasekar
1Department of Pediatrics, University of California, San Diego and Rady Children's Hospital San Diego, La Jolla, CA 92093, USA. atremoulet@ucsd.edu
Insights
Kawasaki disease (KD) laboratory values change predictably during illness and after intravenous immunoglobulin (IVIG) treatment. Tracking these dynamic changes aids in diagnosing KD and assessing coronary artery outcomes.
Area of Science:
- Pediatrics
- Infectious Diseases
- Clinical Pathology
Background:
- Diagnosis of Kawasaki disease (KD) relies on clinical laboratory studies per American Heart Association guidelines.
- Detailed evolution of laboratory values during KD illness has not been previously reported.
Purpose of the Study:
- To characterize the evolution of clinical laboratory values in KD patients before and after intravenous immunoglobulin (IVIG) treatment.
- To correlate laboratory value changes with treatment response and coronary artery outcomes.
Main Methods:
- Analysis of laboratory values from 380 KD patients at acute, subacute, and convalescent phases.
- Stratification of results by IVIG response and coronary artery outcome.
Main Results:
- White blood cell count, ESR, and CRP peaked in the acute phase; platelet count peaked in the subacute phase; lymphocytes and eosinophils peaked in the convalescent phase.
- Patients with coronary artery aneurysms showed higher WBC in the subacute phase and higher ESR in subacute and convalescent phases.
Conclusions:
- Consistent evolution of laboratory values is observed in KD before and after treatment.
- Understanding dynamic laboratory changes aids physicians in diagnosing KD using American Heart Association guidelines.
Background:
As outlined in the 2004 American Heart Association guidelines, the diagnosis of Kawasaki disease (KD) is supported by results of clinical laboratory studies. However, detailed information regarding the evolution of these results during illness has not been previously reported. The goals of this project were to characterize the evolution of clinical laboratory values in KD before and after treatment with intravenous immunoglobulin (IVIG).
Methods:
Laboratory values from 380 unselected, consecutive KD patients were analyzed at 3 times: acute (illness day, 2-10; illness day 1 = first day of fever and before IVIG), subacute (illness day, 11-21), and convalescent (illness day, 22-60). Results were stratified by IVIG response and coronary artery outcome.
Results:
Although white blood cell count, percentage bands, erythrocyte sedimentation rate, and C-reactive protein values were highest and age-adjusted hemoglobin was lowest in the acute phase before IVIG, platelet count was highest in the subacute phase, and percentage lymphocytes and eosinophils were highest in the convalescent phase after IVIG. KD patients with coronary artery aneurysms had a higher white blood cell count in the subacute phase and higher erythrocyte sedimentation rate in the subacute and convalescent phases compared with those with dilated or normal coronary arteries.
Conclusions:
A consistent evolution of laboratory values is associated with KD before and after treatment. Understanding the dynamic changes in laboratory values can assist physicians in using laboratory criteria to diagnose KD following the American Heart Association guidelines.
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Endocarditis II: Clinical Features of Infective Endocarditis
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease II: Clinical Manifestations
Myocarditis II: Clinical Features and Diagnostic Tests
Acute Kidney Injury III: Clinical Manifestations
